Related Experiment Video
Updated: Oct 7, 2025

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
Genetic Background of Fetal Growth Restriction
Beata Anna Nowakowska1, Katarzyna Pankiewicz2, Urszula Nowacka2
1Department of Medical Genetics, Institute of Mother and Child, Kasprzaka 17a, 01-211 Warsaw, Poland.
Insights
Fetal growth restriction (FGR) poses significant risks, leading to adverse outcomes. This review explores genetic causes and diagnostic tools like chromosomal microarray and noninvasive prenatal testing for FGR.
Area of Science:
- Obstetrics and Gynecology
- Medical Genetics
- Prenatal Diagnostics
Background:
- Fetal growth restriction (FGR) is a major complication in antenatal care, linked to stillbirth, neonatal morbidity, and long-term health issues like metabolic diseases.
- Understanding the genetic underpinnings of FGR is crucial for improving prenatal diagnostics and patient outcomes.
- Pathological fetal growth has severe consequences, extending beyond fetal demise to developmental challenges and chronic conditions such as hypertension and diabetes mellitus.
Purpose of the Study:
- To review the current knowledge on genetic disturbances causing FGR.
- To analyze the impact of these genetic factors on prenatal diagnostic approaches.
- To highlight the role of chromosomal microarray (CMA) and noninvasive prenatal testing (NIPT) in FGR diagnosis.
Main Methods:
- Literature review of genetic causes of FGR.
- Analysis of diagnostic techniques including CMA and NIPT.
- Categorization of FGR causes into fetal, placental, and maternal factors.
Main Results:
- Genetic disturbances are key factors in FGR etiology.
- CMA and NIPT offer advanced prenatal diagnostic capabilities for FGR.
- Distinguishing between fetal, placental, and maternal genetic causes is essential for targeted management.
Conclusions:
- Genetic factors significantly contribute to fetal growth restriction.
- Advanced prenatal testing methods like CMA and NIPT are vital for accurate FGR diagnosis.
- Further research into genetic disturbances can optimize antenatal care strategies for FGR.
Abstract:
Fetal growth restriction (FGR) is one of the most formidable challenges in present-day antenatal care. Pathological fetal growth is a well-known factor of not only in utero demise in the third trimester, but also postnatal morbidity and unfavorable developmental outcomes, including long-term sequalae such as metabolic diseases, diabetic mellitus or hypertension. In this review, the authors present the current state of knowledge about the genetic disturbances responsible for FGR diagnosis, divided into fetal, placental and maternal causes (including preeclampsia), as well as their impact on prenatal diagnostics, with particular attention on chromosomal microarray (CMA) and noninvasive prenatal testing technique (NIPT).
Related Concept Videos
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Nature and Nurture
Teratogenicity
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Gene-Environment Interactions
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...

